AUTHORS
D. Carey1, G. Musoro2, D. Boettiger1, E. Papot1, S. Wagner3, R. Kaplan4, B. Jones5, M. Law1, G. Matthews1, on behalf of the D2EFT Study Group
INSTITUTIONS
1University of New South Wales, Kirby Institute, Sydney, Australia, 2University of Zimbabwe, Clinical Research Centre, Harare, Zimbabwe, 3INI, Rio de Janiero, Brazil, 4Desmond Tutu Health Foundation, Cape Town, South Africa, 5ViiV Healthcare, Brentford, United Kingdom
D. Carey1, G. Musoro2, D. Boettiger1, E. Papot1, S. Wagner3, R. Kaplan4, B. Jones5, M. Law1, G. Matthews1, on behalf of the D2EFT Study Group
INSTITUTIONS
1University of New South Wales, Kirby Institute, Sydney, Australia, 2University of Zimbabwe, Clinical Research Centre, Harare, Zimbabwe, 3INI, Rio de Janiero, Brazil, 4Desmond Tutu Health Foundation, Cape Town, South Africa, 5ViiV Healthcare, Brentford, United Kingdom